Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection Ruchika Sharma1 April 2025 12:15 PM ISTThe patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.
Zaynich shows over 97 percent efficacy for drug-resistant bacteria: Wockhardt Ruchika Sharma13 Jan 2025 1:06 PM ISTMumbai: Wockhardt has announced that Zaynich (Zidebactam/Cefepime, WCK 5222) demonstrated over 97 percent clinical efficacy in treating...
USFDA grants fast track designation to Wockhardt novel antibiotic WCK 6777 Ruchika Sharma8 Oct 2024 10:30 AM ISTMumbai: Wockhardt has announced that its unique once-a-day, β-lactam enhancer based MDR-active antibiotic, WCK 6777 (Ertapenem/Zidebactam) has...
CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
Wockhardt Gets CDSCO Panel Nod To study combination of cefepime and zidebactam. Dr. Divya Colin16 Jan 2024 5:00 PM ISTNew Delhi: The drug major Wockhardt has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel grants Wockhardt's Protocol Amendment Proposal For Cefepime Zidebactam Dr. Divya Colin11 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
